Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.
Tsukamoto. Emi E; Hashimoto. Yuichi Y; Kanekura. Kohsuke K; Niikura. Takako T; Aiso. Sadakazu S; Nishimoto. Ikuo I
Key Findings
- Amyloid‑beta kills neurons that have the p75NTR receptor via a pathway involving Gαo, JNK, NADPH oxidase, and caspases
- A mutant p75NTR (L401K) does not mediate this toxicity
- Humanin (along with IGF‑I, bFGF) blocks the amyloid‑beta‑induced cell death in primary neuron cultures
Practical Outcomes
- Humanin appears to be a promising neuroprotective agent against amyloid‑beta toxicity, suggesting it could be explored as part of an anti‑aging or brain‑health regimen. However, no human dosing or safety data are provided, so any use would be experimental and should be approached with caution.
Summary
The study shows that the protein humanin can protect brain cells from the toxic effects of Alzheimer’s‑related amyloid‑beta by blocking a specific cell‑death pathway, but the work was done in lab‑grown cells, not people.
Abstract
Neuronal pathology of the brain with Alzheimer's disease (AD) is characterized by numerous depositions of amyloid-beta peptides (Abeta). Abeta binding to the 75-kDa neurotrophin receptor (p75NTR) causes neuronal cell death. Here we report that Abeta causes cell death in neuronal hybrid cells transfected with p75NTR, but not in nontransfected cells, and that p75NTR(L401K) cannot mediate Abeta neurotoxicity. We analyzed the cytotoxic pathway by transfecting pertussis toxin (PTX)-resistant G protein alpha subunits in the presence of PTX and identified that Galpha(o), but not Galpha(i), proteins are involved in p75NTR-mediated Abeta neurotoxicity. Further investigation suggested that Abeta neurotoxicity via p75NTR involved JNK, NADPH oxidase, and caspases-9/3 and was inhibited by activity-dependent neurotrophic factor, insulin-like growth factor-I, basic fibroblast growth factor, and Humanin, as observed in primary neuron cultures. Understanding the Abeta neurotoxic mechanism would contribute significantly to the development of anti-AD therapies.
Study Information
pubmed
2003
2003-09-01T00:00:00.000Z
10.1002/jnr.10703
84
56